JOSEPH LAPENNA: Open Payments
NPI 1154828465 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 12 payments from 7 companies in 2025. Trend: 2023 $23 · 2024 $357 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $73 |
| SPR Therapeutics, Inc | 2 | $62 |
| Medtronic, Inc. | 2 | $56 |
| Averitas Pharma Inc. | 1 | $38 |
| SCILEX PHARMACEUTICALS INC. | 2 | $36 |
| REVANCE THERAPEUTICS, INC. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: JOURNAVX, SPRINT PNS System, INCEPTIV, QUTENZA, ZTLido, DAXXIFY, Belbuca.
Industry payments across CA — which companies pay providers there.
